RARE CANCER AGENDA 2030 – Ten Recommendations from the EU Joint Action on Rare CancersJune 2020Read More
EURORDIS response to European Ombudsman strategic inquiry into pre-submission activities organised by the European Medicines AgencyFebruary 2019Read More
EURORDIS Recommendations on the Integration of European Reference Networks into National Health SystemsNovember 2018Read More
The Voice of Rare Disease Patients: Experiences and Expectations of over 3,000 PatientsDecember 2013Read More
EURORDIS Contribution to the European Commission Public Consultation on the Revision of the “Clinical Trial Directive”February 2012Read More
This site is registered on wpml.org as a development site.